Testing a breath marker to guide care for newborn jaundice
Part of Blood & lymphatic clinical trials.
This study looks at a breath-related measurement (from the air you exhale) to help diagnose and guide treatment for jaundice in certain newborns. It may help the care team better decide what care you need after birth, especially when jaundice is related to blood type mismatch.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Babies must be born at 35 weeks 0 days through 41 weeks 6 days
- Birth weight must be at least 2500 grams
- Your baby’s breathing rate must be under 60 breaths per minute
- Baby is admitted to the newborn unit for light therapy (phototherapy) for high bilirubin (jaundice)
- Jaundice must be linked to mother-and-baby blood type mismatch (ABO incompatibility)
- A parent/guardian must sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple breath test to measure carbon monoxide levels in newborns, which may help doctors better manage jaundice. It aims to understand how these levels change and how they relate to jaundice treatment.
This trial uses a special breath test (ETCOc) to measure jaundice in newborns, aiming to improve diagnosis and treatment. It may help doctors decide when treatment is needed.
This study checks if a light-based device can measure bilirubin levels accurately without a blood test, by comparing it with the standard blood test. It looks at newborns of different skin colours to make sure the device works for everyone.
This study is looking at a new scoring system to help doctors quickly tell how severe jaundice is in newborns. The goal is to better decide when a baby needs stronger treatment like a blood exchange, so the right care can be given sooner.
This study tests a new phototherapy (special light treatment) device to treat newborn jaundice. It may help by seeing whether this device can treat jaundice safely and effectively.
This study tests a device that measures jaundice level through the skin without needing a blood test. It is for newborns who need light therapy.
Hear when a new ABO Hemolytic Disease of Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.